Abstract

Sphenocentrum jollyanum whole stem extract is used traditionally in combination with its leaves to treat chronic wounds and also ameliorate conditions that exacerbate wounds such as diabetes mellitus. The study isolated the major wound healing bioactive compound from the non-polar fraction of S. jollyanum extract and evaluated the in vivo wound healing activity of a 0.10% w/w 1,4-polyisoprene-based ointment in streptozotocin-induced diabetic rats. The major bioactive constituent of S. jollyanum was isolated using a wound healing activity-guided approach and characterized the compound using 1D and 2D-NMR spectroscopic techniques. The wound healing activity study adopted both excision (wound contraction) and incision (biochemical) models. In the excision model, the 1,4-polyisoprene caused 99% wound closure and restored the excised wound on day 12. On the 6th and 12th post-wounding days, 1,4-polyisoprene caused a significant (p<0.001) elevation in the tensile strength (486g) of the incision wound compared with the control (388g). The biochemical (hexosamine and hydroxyproline) and antioxidant/inflammatory (ascorbic acid, superoxide dismutase, and glutathione peroxidase) parameters increased significantly while malondialdehyde was down-regulated in the wounds treated with 1,4-polyisoprene compared with control. The histological analysis of tissue sections taken from the edge and center of the wounds at 0-12 days post wounding revealed an increased tissue regeneration, accelerated collagen formation, and epidermal regeneration without edema or inflammation on the 12th day. The major wound healing constituent of S. jollyanum is 1,4-polyisoprene and the study has provided a new class of compounds for further optimization.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call